Antibe Therapeutics Inc (ATBPF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 06-2016 | 03-2016 | 12-2015 | 09-2015 | 06-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,271 | 711 | 1,376 | 361 | 970 |
| Marketable Securities | 19 | 19 | 19 | 19 | 20 |
| Receivables | 1,145 | 1,143 | 1,020 | 214 | 206 |
| Inventories | 2,079 | 1,814 | 1,910 | N/A | N/A |
| TOTAL | $4,626 | $3,828 | $4,476 | $646 | $1,239 |
| Non-Current Assets | |||||
| PPE Net | 61 | 62 | 63 | N/A | N/A |
| Intangibles | 3,429 | 3,437 | 2,826 | 0 | 0 |
| Other Non-Current Assets | 119 | 115 | 75 | 12 | 13 |
| TOTAL | $3,609 | $3,613 | $2,964 | $12 | $13 |
| Total Assets | $8,236 | $7,442 | $7,440 | $658 | $1,252 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 53 | 75 | 122 | N/A | N/A |
| Accounts payable and accrued liabilities | 1,498 | 1,041 | 823 | 297 | 318 |
| TOTAL | $2,536 | $2,296 | $2,060 | $297 | $318 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | 8 | N/A | N/A |
| Other Non-Current Liabilities | 1,699 | 1,549 | 1,412 | 0 | 0 |
| TOTAL | $1,699 | $1,549 | $1,420 | $N/A | $N/A |
| Total Liabilities | $4,235 | $3,845 | $3,480 | $297 | $318 |
| Shareholders' Equity | |||||
| Common Shares | 10,825 | 10,018 | 9,971 | 6,683 | 7,107 |
| Retained earnings | -11,417 | -10,395 | -9,634 | -9,260 | -9,238 |
| Other shareholders' equity | 2,002 | 1,608 | 1,561 | 1,043 | 1,110 |
| TOTAL | $4,001 | $3,597 | $3,960 | $361 | $934 |
| Total Liabilities And Equity | $8,236 | $7,441 | $7,440 | $658 | $1,252 |